Bavarian Nordic A/S
10.11.2025 21:00:00 CET | Globenewswire | Press release
Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley
Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley
COPENHAGEN, Denmark, November 10, 2025 – Pursuant to section 30 of the Danish Capital Markets Act, Bavarian Nordic A/S hereby announces that the Company has received notification from Morgan Stanley that they hold 4,94% of the shares and voting rights in Bavarian Nordic A/S as of November 4, 2025.
About Bavarian Nordic
Bavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines. We are a preferred supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and have a leading portfolio of travel vaccines. For more information, visit www.bavarian-nordic.com.
Contact investors:
Europe: Disa Tuominen, IR Manager, detu@bavarian-nordic.com
US: Graham Morrell, Gilmartin Group, graham@gilmartinir.com, Tel: +1 781 686 9600
Contact media:
Nicole Seroff, Vice President Corporate Communications, nise@bavarian-nordic.com, Tel: +45 53 88 06 03
Company Announcement no. 42 / 2025
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Jyske Realkredit A/S1.4.2026 09:26:16 CEST | Press release
Cash Flows
Jyske Realkredit A/S1.4.2026 09:26:16 CEST | Pressemeddelelse
Ydelsesrækker
Genmab A/S1.4.2026 09:24:36 CEST | Press release
Major Shareholder Announcement
NTG Nordic Transport Group A/S1.4.2026 09:16:26 CEST | Press release
NTG Nordic Transport Group (“NTG”) announces the appointment of Carsten Trolle as CEO of its Air & Ocean division
Virtune AB (Publ)1.4.2026 09:03:25 CEST | Press release
Virtune strengthens its Nordic presence by appointing a Country Manager for Finland
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom